Twelve Indicted In $4.53 Million Rebate Case Involving Korea’s Dong-A
This article was originally published in PharmAsia News
Executive Summary
Instead of providing rebates through its own sales representatives, Korea’s largest domestic company tried to sidestep anti-rebate laws using marketing and distribution agencies to provide rebates to hospitals and doctors.